NEW YORK, Jan 22 – The Nasdaq said Monday it had slashed the number of companies it would include in its biotechnology index from 202 to 76, including a number of genomics companies that recently raised tens of millions of dollars last year but have since seen their share prices fall.

The change in the index will be effective Tuesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.